Skip to main content

Intercure Ltd.

INCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001857030

No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Intercure Ltd. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of INCR: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders216+14
Shares753.0K2.36M+1.60M (+213.0%)
Value$5.37M$16.3M+$10.9M (+203.7%)

New holders (14)

Institutions that held Intercure Ltd. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to INCR in Q3 2021
InstitutionSharesValue% of portfolio
Ibex Investors LLC1,356,054$9.40M6.49%
Healthcare of Ontario Pension Plan Trust Fund212,500$1.47M0.00%
UBS Group AG114,220$792.0K0.00%
Marshall Wace, LLP112,947$776.0K0.00%
Jane Street Group, LLC49,093$337.0K0.00%
Goldman Sachs Group Inc40,790$283.0K0.00%
Citadel Advisors LLC28,242$196.0K0.00%
Bank of America Corp5,164$36.0K0.00%
Morgan Stanley4,608$32.0K0.00%
Advisor Group Holdings, Inc.500$3.00K0.00%
Royal Bank of Canada101$1.00K0.00%
Sugarloaf Wealth Management, LLC200$1.00K0.00%
McCarthy Asset Management, Inc.150$1.00K0.00%
Toronto Dominion Bank14$00.00%

Sold out (0)

Institutions that held Intercure Ltd. at the end of Q2 2021 and filed for Q3 2021 without it.

None.